Getinge AB (publ)
Climate Impact & Sustainability Data (2022, 2023, 2024-04-01 to 2024-06-30)
Reporting Period: 2022
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:60%+
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Carbon neutrality
- Sustainability
- Quality
- Responsible Leadership
- Ethical decision-making
Environmental Achievements
- Reduced total carbon emissions in production by 48% year-on-year.
- Achieved over 60% renewable energy in production.
- All production sites in Life Science became carbon neutral during the year.
- Launched Aquadis 56 washer-disinfector, which uses less energy, water and detergents.
Social Achievements
- Entered into a partnership with the International Finance Corporation (IFC) to increase access to medical equipment in Africa.
- Donated medical devices to the Heart Institute of Ukraine.
- Announced support of the American Heart Association’s initiative to develop healthcare for patients with cardiogenic shock.
- Offered employees paid time off for volunteer work.
- Presented global guidelines offering all employees paid family leave.
Governance Achievements
- Established a new Operational Services function.
- Relocated Corporate Internal Audit operations from external resources to an internal organization.
- Worked more closely with root cause analysis for various risks.
- Worked on business continuity risks.
Climate Goals & Targets
Long-term Goals:
- Net-zero emission company by 2050
Medium-term Goals:
- Carbon neutral in own operations by 2025
- Improved customer quality index >70%
- Employee commitment >70%
Short-term Goals:
- Not disclosed
Environmental Challenges
- Supply chain problems (component shortages, logistical difficulties, higher costs).
- Global inflation impacting customers’ finances.
- Healthcare not yet recovered to pre-pandemic levels.
- Difficulty in reducing Scope 3 emissions.
- Potential violations of German medical device laws (whistleblower investigation).
Mitigation Strategies
- Actively worked with suppliers to mitigate supply chain limitations and reduce cost increases.
- Focused on spreading knowledge of products and services that increase healthcare productivity.
- Submitted carbon emissions for the entire value chain to the Science Based Target initiative.
- Implemented corrective measures regarding packaging and strengthened quality culture.
- Fully cooperating with the prosecution authority.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Active monitoring of critical suppliers.
Climate-Related Risks & Opportunities
Physical Risks
- Natural disasters
Transition Risks
- Regulatory changes
Opportunities
- Development of energy-efficient products
Reporting Standards
Frameworks Used: GRI
Certifications: ISO 13485, ISO 9001, ISO 14001
Third-party Assurance: Öhrlings PricewaterhouseCoopers AB (limited assurance for Sustainability Report)
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- IN2 modular room system
- Aquadis 56 washer-disinfector
- Updated ED-Flow endoscope reprocessor
- Vac-a-Scope benchtop packaging system
- DPTE®-EXO Alpha Port
- Livit Flex bioprocess control system
Awards & Recognition
- IF Design Award for GUIDE
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:4,509 tCO2e/year (Scope 1 & 2)
Scope 1 Emissions:3,895 tCO2e/year
Scope 2 Emissions:614 tCO2e/year
Renewable Energy Share:67% of total energy use
Total Energy Consumption:76,813 MWh/year
Waste Generated:2,739 tons/year
Carbon Intensity:0.284 tons CO2e/SEK M internal sales in 2023
ESG Focus Areas
- Excel in quality and responsible business
- Engaged employees
- Sustainable innovations for better health
Environmental Achievements
- 67% of energy in production worldwide from renewable sources
- Reduced CO₂ emissions intensity from production by 75% compared to 2019
- Reduced energy consumption intensity in production by 16% compared to 2019
Social Achievements
- 72% improved customer quality index (target over 70%)
- 4 of 6 of Getinge’s largest Global Sales and Service organizations are led by women
- Employee Engagement Index >70% (scored 71%)
- Work-related accident rate (WRAR) of 0.89 (target below 1.3)
Governance Achievements
- Continued development and rollout of the Responsible Leadership program
- Implemented a process and tools for improved risk assessment of business partners
Climate Goals & Targets
Long-term Goals:
- Net-zero emissions by 2050
Medium-term Goals:
- Reduce absolute Scope 1 and 2 GHG emissions by 90% by 2030 from a 2021 base year
- Reduce absolute Scope 3 GHG emissions by 25% by 2030 from a 2021 base year
Short-term Goals:
- Reduce CO₂ emissions intensity from production by 5% by 2024 (compared to 2019)
- Reduce energy consumption intensity in production by 10% by 2024 (compared to 2019)
- 50% of vehicles to have low-emission power units by 2025
- WRAR below 1 by 2025
- >95% of waste from production recycled by 2025
Environmental Challenges
- Reducing waste generated in production, particularly packaging
- Reducing Scope 3 emissions (primarily from purchased goods and services, logistics, and product use)
- Achieving gender balance across the company
- Managing risks in the supply chain related to ethical sourcing, human rights, and environmental impact
Mitigation Strategies
- Setting Science Based Targets (SBTi) validated net-zero targets by 2050
- Implementing Ecodesign processes in R&D
- Exploring circular business models
- Reducing water and energy use in production
- Minimizing and recycling waste
- Engaging with suppliers to reduce emissions and improve sustainability practices
- Implementing a systematic work method to improve gender balance in senior positions
- Developing a solution for risk assessment of all Tier 1 suppliers
Supply Chain Management
Responsible Procurement
- Business Partner Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather and rising sea levels impacting supply chain
Transition Risks
- Regulatory changes, market shifts
Opportunities
- Development of energy-efficient products
Reporting Standards
Frameworks Used: GRI, SASB, SBTi, UNGC, ESRS (in preparation)
Certifications: ISO 9001, ISO 13485, ISO 14001 (except for some recently acquired units)
UN Sustainable Development Goals
- Goal 3
- Goal 4
- Goal 5
- Goal 6
- Goal 8
- Goal 12
- Goal 13
- Goal 17
Getinge supports all 17 SDGs, focusing on those most relevant to its business and stakeholders.
Awards & Recognition
- WIN WIN Gothenburg Sustainability Award
Reporting Period: 2024-04-01 to 2024-06-30
Environmental Metrics
Total Carbon Emissions:4,570 tCO2e
Renewable Energy Share:67%
Total Energy Consumption:76,919 MWh
ESG Focus Areas
- Social
- Environmental
- Governance
Environmental Achievements
- Launched a new version of the DPTE-BetaBag® made of plastic from renewable sources, reducing the carbon footprint.
- Launched GEW 888 neo washer that increases clean room efficiency and helps reduce water consumption by 20%.
- Placed an order for international renewable energy certificates (RECs) corresponding to a full-year consumption for two production sites (to be received in Q3).
Social Achievements
- Employee engagement remained at 71%
- Positive downward trend in sick leave compared with full-year 2023.
- Improved product quality KPI for Q2 2024 after a higher number of field actions in 2023 (mainly related to Cardiosave).
Governance Achievements
- Percentage of employees who completed training in business ethics: 89%
Climate Goals & Targets
Long-term Goals:
- Reduce Scope 3 emissions by 90% by 2050
- Employee engagement: >70%
- Quality regulatory compliance, audit results/inspection: <1.5 deviation
- Percentage of employees who completed training in business ethics: >90%
Medium-term Goals:
- Reduce Scope 1 and 2 emissions by 90% by 2030
- Reduce Scope 3 emissions by 25% by 2030
Environmental Challenges
- FDA letter to healthcare providers in the US recommending alternatives to Getinge’s Cardiosave, Cardiohelp, and HLS sets.
- Continued soft market for Bio-Processing in Life Science.
- Lower sales in Infection Control in Surgical Workflows.
Mitigation Strategies
- Suspended active marketing of related products in the US and accelerated improvement measures.
- Accelerated improvement measures and schedule for the next generation of products.
- Outgoing deliveries in capital goods for Life Science moved to the second half of the year.
- Ongoing efforts to enhance the efficiency of the customer offering in Surgical Workflows.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI, ESRS
Certifications: ISO 13485, ISO 9001
Sustainable Products & Innovation
- GEW 888 neo washer
- New version of the DPTE-BetaBag®
- Lancer LSS sterilizer
- Poladus 150 sterilizer
- Talis Advanced Clinical Guidance software